BioGaia AB (STU:BGLA) Total Operating Expense: €65.1 Mil (TTM As of Mar. 2026)


STU:BGLA BioGaia AB STU:BGLA
94 GF Score
Price €10.70
GF Value €11.77
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is BioGaia AB Total Operating Expense?

BioGaia AB STU:BGLA +0.38% 94 Total Operating Expense is €65.1 Mil as of Mar. 2026. GuruFocus rates STU:BGLA with a GF Score™ of 94/100 and a GF Value™ of €11.77 (Fairly Valued). The stock has 5 warning signs investors should review.

BioGaia AB's Total Operating Expense for the three months ended in Mar. 2026 was €15.4 Mil. BioGaia AB's Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 was €65.1 Mil.

BioGaia AB Total Operating Expense Related Terms

BioGaia AB Total Operating Expense Historical Data

* Premium members only.

The historical data trend for BioGaia AB's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BioGaia AB Total Operating Expense Chart

BioGaia AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 33.15 42.52 45.53 54.02 62.18

BioGaia AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 15.63 16.85 14.23 18.64 15.38
STU:BGLA
94GF Score
BioGaia AB STU:BGLA
Total Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

BioGaia AB Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €65.1 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of €65.1 Mil mean?
BioGaia AB (STU:BGLA) has a Total Operating Expense of €65.1 Mil as of Mar. 2026. Total operating expense is the primary recurring expense associated with central operations. View historical data on BioGaia AB and its competitors.
Is BioGaia AB's Total Operating Expense too high?
BioGaia AB's current Total Operating Expense is €65.1 Mil. Overall, BioGaia AB has a GF Score™ of 94/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does BioGaia AB's Total Operating Expense compare to ZTS and UTHR?
BioGaia AB's Total Operating Expense of €65.1 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Drug Manufacturers company?
A good Total Operating Expense depends on the Drug Manufacturers industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on BioGaia AB and its competitors. BioGaia AB's current Total Operating Expense is €65.1 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BioGaia AB stock overvalued right now?
Based on GuruFocus' analysis, BioGaia AB (STU:BGLA) is currently considered Fairly Valued. The stock's GF Value™ is €11.77, compared to a current price of €10.70 — trading 9.1% below its estimated fair value. The current Total Operating Expense is €65.1 Mil. BioGaia AB's overall GF Score™ is 94/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For BioGaia AB (STU:BGLA), the current Total Operating Expense is €65.1 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is BioGaia AB (STU:BGLA) Overvalued in 2026?

Based on GuruFocus' analysis, BioGaia AB stock appears to be undervalued. The current stock price of €10.70 is trading 9.1% below its estimated GF Value™ of €11.77. GuruFocus considers BioGaia AB to be Fairly Valued.

Key valuation signals for STU:BGLA:

  • Total Operating Expense: €65.1 Mil
  • GF Value™: €11.77 vs. price of €10.70 (9.1% below fair value)
  • GF Score™: 94/100 with 5 warning signs

No single metric tells the full story. See the STU:BGLA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

BioGaia AB Business Description

Other Exchanges BIOG B:Sweden0GTN:UK
Address Kungsbroplan 3A, Stockholm, SWE, SE-112 27
BioGaia AB is a healthcare company engaged in developing, marketing, and selling probiotic products. The company has three operating segments; Paediatrics segment includes drops, gut health tablets, oral rehydration solution (ORS) and cultures to be used as ingredients in licensee products such as infant formula, as well as royalty revenue for pediatric products, Adult Health segment includes gut health tablets, oral health lozenges and cultures as an ingredient in a licensee's dairy products, and Other segment include royalties in respect of development projects, revenue from packaging solutions in the subsidiary CapAble, etc. Geographically, it operates in three regions: EMEA, the Americas, and APAC (Asia-Pacific, Australia, and New Zealand).
94GF Score

Get the complete analysis for STU:BGLA

Total Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€10.70
Price
€11.77
GF Value